A detailed history of Aa Financial Advisors, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Aa Financial Advisors, LLC holds 386 shares of REGN stock, worth $318,249. This represents 0.12% of its overall portfolio holdings.

Number of Shares
386
Previous 345 11.88%
Holding current value
$318,249
Previous $363 Million 11.91%
% of portfolio
0.12%
Previous 0.13%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$1024.09 - $1201.76 $41,987 - $49,272
41 Added 11.88%
386 $406 Million
Q2 2024

Jul 16, 2024

BUY
$883.2 - $1071.19 $37,977 - $46,061
43 Added 14.24%
345 $363 Million
Q1 2024

May 03, 2024

BUY
$902.69 - $993.35 $272,612 - $299,991
302 New
302 $291 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $88.4B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Aa Financial Advisors, LLC Portfolio

Follow Aa Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aa Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aa Financial Advisors, LLC with notifications on news.